The histomorphology of lynch syndrome-associated ovarian carcinomas: Toward a subtype-specific screening strategy

American Journal of Surgical Pathology

Volumn 38, Issue 9, 2014, Pages 1173-1181

  Chui, Michael Herman ^a   Ryan, Paul ^k   Radigan, Jordan ^a   Ferguson, Sarah E ^b,c   Pollett, Aaron ^a,e   Aronson, Melyssa ^f   Semotiuk, Kara ^f   Holter, Spring ^f   Sy, Keiyan ^a   Kwon, Janice S ^c,j   Soma, Anita ^l   Singh, Naveena ^l   Gallinger, Steven ^g   Shaw, Patricia ^a,d   Arseneau, Jocelyne ^h   Foulkes, William D ^h   Gilks, C Blake ⁱ   Clarke, Blaise A ^a,d  

^a Department of Brain Sciences   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Division of Gynecologic Oncology   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e Department of Laboratory Medicine and Pathology ^*  (Canada)

^f Zane Cohen Centre for Digestive Diseases   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j BON SECOURS HOSPITAL   (Ireland)

^k KING EDWARD MEMORIAL HOSPITAL   (Australia)

^l BARTS HEALTH NHS TRUST   (United Kingdom)

more..

Author keywords

Lynch syndrome; mismatch repair; ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOPSY; CANADA; CANCER GRADING; CHEMISTRY; CLASSIFICATION; EARLY DIAGNOSIS; ENDOMETRIOID CARCINOMA; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GERMLINE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HEREDITY; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE; REGISTER; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BIOPSY; BRCA1 PROTEIN; BRCA2 PROTEIN; CANADA; CARCINOMA, ENDOMETRIOID; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HEREDITY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM GRADING; OVARIAN NEOPLASMS; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REGISTRIES;

EID: 84906794547     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000298     Document Type: Article

References (35)

1. Watson P, Riley B. The tumor spectrum in the Lynch syndrome. Fam Cancer. 2005;4:245-248.
2. Watson P, Vasen HF, Mecklin JP, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 2008;123:444-449.
3. Pal T, Permuth-Wey J, Sellers TA. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer. 2008; 113:733-742.
4. Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105:569-574.
5. Schmeler KM, Lu KH. Gynecologic cancers associated with Lynch syndrome/HNPCC. Clin Transl Oncol. 2008;10:313-317.
6. Malander S, Rambech E, Kristoffersson U, et al. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecol Oncol. 2006;101: 238-243.
7. Zhang S, Royer R, Li S, et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol. 2011;121:353-357.
8. Pal T, Akbari MR, Sun P, et al. Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. Br J Cancer. 2012;107:1783-1790.
9. ACOG Practice Bulletin No. 103. Hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113:957-966.
10. Bewtra C, Watson P, Conway T, et al. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol. 1992;11: 180-187.
11. Schrader KA, Hurlburt J, Kalloger SE, et al. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstet Gynecol. 2012;120:235-240.
12. Lund B, Thomsen HK, Olsen J. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications. APMIS.; 1991:353-358.
13. Cramer SF, Roth LM, Ulbright TM, et al. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology. Arch Pathol Lab Med. 1987;111:819-829.
14. Kobel M, Kalloger SE, Baker PM, et al. Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study. Am J Surg Pathol. 2010;34:984-993.
15. Kobel M, Bak J, Bertelsen BI, et al. Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology. 2014;64:1004-1013.
16. Lancaster JM, Powell CB, Kauff ND, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007;107:159-162.
17. Truta B, Chen YY, Blanco AM, et al. Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Fam Cancer. 2008;7:267-274.
18. Ryan P, Mulligan AM, Aronson M, et al. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Cancer. 2012;118:681-688.
19. Soslow RA, Han G, Park KJ, et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol. 2012;25:625-636.
20. Clarke BA, Cooper K. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas. Adv Anat Pathol. 2012;19:231-238.
21. Pal T, Permuth-Wey J, Kumar A, et al. Systematic review and metaanalysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res. 2008;14:6847-6854.
22. Howlader NNA, Krapcho M, Garshell J, et al. SEER Cancer Statistics Review, 1975-2010. website. Available at: http://seer.cancer. gov/csr/19752010/. Accessed November 22, 2013.
23. Gilks CB, Ionescu DN, Kalloger SE, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol. 2008;39:1239-1251.
24. Bonadona V, Bonaiti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. Jama. 2011;305:2304-2310.
25. Chui MH, Gilks CB, Cooper K, et al. Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype. Adv Anat Pathol. 2013;20:378-386.
26. Engel C, Loeffler M, Steinke V, et al. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol. 2012;30:4409-4415.
27. Watson P, Butzow R, Lynch HT, et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol. 2001;82:223-228.
28. Casey MJ, Bewtra C, Lynch HT, et al. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry. Fam Cancer. 2013;12:719-740.
29. Palma L, Marcus V, Gilbert L, et al. Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery. Gynecol Oncol. 2008;111:575-578.
30. Aysal A, Karnezis A, Medhi I, et al. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012;36:163-172.
31. Barnetson R, Jass J, Tse R, et al. Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity. Genes Chromosomes Cancer. 2000; 29:130-136.
32. Guerra F, Girolimetti G, Perrone AM, et al. Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers. Mod Pathol. 2014. [Epub ahead of print]. doi: 10.1038/modpathol.2014.39.
33. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456-462.
34. Kondi-Pafiti A, Grapsa D, Liapis A, et al. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis? Eur J Gynaecol Oncol. 2008;29:256-259.
35. Soliman PT, Broaddus RR, Schmeler KM, et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J Clin Oncol. 2005;23: 9344-9350.